2019 News Briefs - International Neuromodulation Society

Earlier News:

2019

Company Licenses Noninvasive Vagus Nerve Stimulation Technology

March 12, 2019 - Cala Health, Inc. has licensed noninvasive technology developed from research on transcutaneous vagus nerve stimulation and respiratory-gated vagal afferent nerve stimulation, for its portfolio of wearable therapies for chronic disease. The Massachusetts General Hospital developers of the technology will serve as scientific advisors to the company. (AP News)

Clinical Trial Evaluated Noninvasive Nerve Stimulation in Children with ADHD

March 12, 2019 - A randomized, double-blind trial evaluated trigeminal nerve stimulation in children with attention deficit hyperactivity disorder (ADHD). (Medical Xpress)

Review Covers Therapeutic Developments in Transcranial Magnetic Stimulation

March 12, 2019 - A review article covers recent evidence of advancements in transcranial magnetic stimulation in a range of clinical applications. (MDedge)

Study Tests Noninvasive Brain Stimulation in Worriers

March 7, 2019 - Researchers tested transcutaneous vagus nerve stimulation in chronic worriers, measuring intrusions of negative thought, and worry induction. (University of Leiden)

Journal Reports Data from Comparative Study of Deep Brain Stimulation Targets in Obsessive Compulsive Disorder

March 7, 2019 - A new study in Biological Psychiatry compared which distinct symptoms were improved in obsessive compulsive disorder through deep brain stimulation of two different brain targets. (Science Daily)

Neurosurgeon Discusses Neuromodulation for Epilepsy

March 7, 2019 - An interview presents neuromodulation treatments for epilepsy, including deep brain stimulation. (Neurology Times)

Review Looks at Emergence of Epidural Spinal Cord Stimulation after Spinal Cord Injury

March 6, 2019 - A review article summarizes epidural spinal cord stimulation to facilitate the function of the sensorimotor network after spinal cord injury. (Neuromodulation: Technology at the Neural Interface)

Researchers in Spain Investigate Noninvasive Brain Stimulation and Self-Reported Aggressiveness

March 6, 2019 - Researchers in Spain are testing the effect of transcranial direct current stimulation on aggressive urges, following publication of data in Neuroscience in January. (Futurism)

Neuromodulation Company Announces First Commercial Use of Its Noninvasive Device

March 5, 2019 - Helius Medical Technologies, Inc. announced the first commercial use of its portable neuromodulation stimulator in patients in Canada with balance issues due to mild to moderate traumatic brain injury. (Nasdaq)

Study Follows Pain Patients for 18 Months After Neurostimulator Implant

March 2, 2019 - An article describes a study in which pain patients were followed for 18 months after receiving dorsal root ganglion stimulation. (Health24)

Comparative Study Looks at Impulsiveness in Parkinson's Disease Patients

March 1, 2019 - A journal article summarizes an investigation that compared impulsiveness in Parkinson's disease patients, who were treated with deep brain stimulation of the subthalamic nucleus, with two other groups - healthy control subjects, and Parkinson's patients who only received medication. (Parkinson's News Today)

Researcher Discusses Neurostimulation for Pain

Feb. 26, 2019 - A journal editor speaks about research into high frequency stimulation for pain. (Pain Medicine News)

Presentation Covers Three-Year Follow-Up Results of Neurostimulator in Overactive Bladder

March 2, 2019 - At the Winter 2019 meeting of the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction, an author presented three-year follow-up results of a prospective multi-center study of a wireless implantable tibial nerve stimulator in patients with overactive bladder. (UroToday)

Psychiatry Journal Publishes Recent Developments in Transcranial Magnetic Stimulation

March 2019 - An overview of transcranial magnetic stimulation in Current Psychiatry summarizes recent developments in the therapy. (MDedge)

Pain Fellows Invited to Enroll in a Neuromodulation Video Curriculum to Begin in July

March 1, 2019 -  "Pain Rounds with Dr. D" features interviews and demonstrations with established experts from academia and private practices around the country. Topics will include challenging lead placement, surgical skills, management of complications, patient selection, the evidence behind spinal cord stimulation, case-based scenarios, professional development, and more.

“Pain Rounds with Dr. D” is a video curriculum and research project on the fundamentals of neuromodulation from The Johns Hopkins Department of Anesthesiology, the Division of Pain Medicine and Dr. Shravani Durbhakula. It is a free series (password protected and by subscription only). Fellows who enroll will be expected to view the complete video series and fill out pre/post surveys for research purposes. (Johns Hopkins)

Study Evaluates Longterm Outcomes of Spinal Cord Stimulation in Patients with Critical Limb Ischemia

Feb. 22, 2019 - Co-authors in Russia evaluated one-year outcomes of spinal cord stimulation in patients with critical limb ischemia to see the influence of clinical determinants and factors related to systemic atherosclerosis. (Annals of Vascular Surgery)

Company Submits Sacral Neuromodulation Data for Its Premarket Approval Application

Feb. 26, 2019 - Axonics Modulation Technologies announced that, as an amendment to its premarket approval application, it has submitted clinical data to the FDA about its sacral neuromodulation system for the treatment of urinary and bowel dysfunction. (Business Wire)

Company Announces Insurance Coverage Decision for Vagus Nerve Stimulator to Treat Episodic Headache

Feb. 26, 2019 - The device company electroCore, Inc. announced an insurance coverage decision from Highmark for the company's noninvasive vagus nerve stimulator for abortive treatment of episodic migraine and episodic cluster headaches. The insurer serves more than 5 million patients in Pennsylvania, Delaware, and West Virginia. (Globe Newswire)

Draft Guidance Issued on Development of Brain-Computer Interfaces

Feb. 25, 2019 - The U.S. FDA has issued draft guidance that outlines recommendations for non-clinical testing and clinical study design related to development of brain-computer-interface (BCI) devices for paralyzed patients or amputees. These brain implants are intended to help provide some mobility or sense of touch. The draft guidance will be open for public comment. (Verdict Medical Devices)

Grant Supports Research Into Wireless Nerve Stimulation for Stroke Recovery

Feb. 20, 2019 - The Texas Biomedical Device Center announced a research grant from  of up to $3.5 million from the U.S. National Institutes of Health to support development of wireless nerve stimulation as an enhancement to stroke recovery. (Texas Biomedical Device Center)

Clinical Trial to Begin for Noninvasive Device to Potentially Treat Overactive Bladder

Feb. 25, 2019 - FemPulse Corporation announced plans for a safety-and-performance clinical trial of its non-implanted vaginal ring intended to deliver neurostimulation to help relieve symptoms of overactive bladder. (AP)

Article Compares Amount of Paresthesia in Pain Patients from Different Modes of Neurostimulation

Feb. 25, 2019 - A sub-analysis compared paresthesia coverage of patients' pain in dorsal root ganglion stimulation versus spinal cord stimulation. (Clinical Pain Advisor)

Data Presented at Meeting Concerning Noninvasive Device Investigated for Epileptic Seizures

Feb. 25, 2019 - Neuroelectrics Corporation presented results of its clinical trial of a noninvasive brain stimulation device intended to reduce the frequency of seizures in epilepsy. (Business Wire)

Device Company Founder Describes Path of Technology and Commercial Development

Fall 2018 - In an alumni magazine profile, a device-company founder describes her interest in closed-loop control systems -- initially from a motivation to help regulate insulin levels. The decision was made to start with pain control as the fastest and easiest "roadmap" to get the device on the market. Later, she envisions research into "modalities like thyroid control". (Lift)

Company Says CMS Has Modified a Coverage Decision about Vagus Nerve Stimulation

Feb. 21, 2019 - LivaNova announced the U.S. Centers for Medicare & Medicaid Services (CMS) issued a modified national coverage decision, through a CMS Coverage with Evidence Development framework, which will enable Medicare coverage for its vagus nerve stimulation for treatment-resistant depression when offered through a CMS-approved, double-blind, randomized, placebo-controlled trial with a follow-up of at least one year. (Mass Device)

Journal Article Details a Project to Develop a Closed-Loop, Peripheral, Neural Interface for an Amputee to Operate an Artificial Hand

Feb. 20, 2019 - A report in Science Robotics details a functional electrical stimulation project. In it, a 40-year-old woman in Rome, whose left forearm had been amputated more than two decades ago, was implanted with a peripheral neural interface designed to offer closed-loop control of bionic hands. The investigators included control algorithms intended to provide force and slippage sensations. (Science Robotics)

Company Announces U.S. Launch of Deep Brain Stimulation in Medically Refractory Epilepsy

Feb. 20, 2019 - Medtronic announced the U.S. launch of deep brain stimulation therapy for medically refractory epilepsy. (Globe Newswire)

Presentation Concerns Point-of-Care Ultrasound in Certain Pain Patients

Feb. 19, 2019 - Researchers presented early clinical data about applying ultrasound at point-of-care to potentially address pain in two conditions. (Pain Medicine News)

Article Summarizes Device Options for Headache Disorders

Feb. 18, 2019 - An overview of neuromodulation and stimulation devices for headache disorders says that an increase in device development brought forward additional treatment options. (Neurology Live)

Company Focused on Technology for Powering Neuromodulation Implants Completes $26 Million Series B Financing

Feb. 20, 2019 - Start-up Neuspera, which is pursuing development of power technology for neuromodulation implants, has closed a $12 million final round of its $26 million Series B equity financing. (Cision)

Company Files Pivotal Study Data with FDA

Feb. 20, 2019 - Axonics has filed interim clinical data with the FDA from its pivotal study of its sacral neuromodulation system for the treatment of urinary and bowel dysfunction. (NeuroNews)

First Patient Implanted in a Pilot Trial of Deep Brain Stimulation in Treatment-Resistant Post-Traumatic Stress Disorder

Feb. 18, 2019 - A woman with treatment-resistant post-traumatic stress disorder in Canada has become the first person in a pilot trial in Toronto to be implanted with a deep brain stimulation system targeting the subgenual cingulate system. The trial will enroll up to five people. (The Globe and Mail)

Neurostimulator Receives CE Mark to Treat Overactive Bladder

Feb. 18, 2019 - Bioness, Inc. announced its tibial nerve stimulator was approved to treat overactive bladder in Europe. (Cision)

Researchers Observe Vagus Nerve Stimulation Effect on Pain Processing

Feb. 13, 2019 - Healthy volunteers were exposed to a painful heat stimulus while undergoing scans of brain activity in a study of vagus nerve stimulation (VNS) effects, prior to an investigation of VNS in military veterans who have post-traumatic stress disorder. (Pain News Network)

Grant Will Fund Feasibility Study of Noninvasive Brain Stimulation in Addiction

Feb. 13, 2019 - Soterix Medical Inc. announced it has been awarded a Small Business Research Innovation Research grant of $475,000 from the National Institute of Drug Abuse of the National Institutes of Health, for a feasibility study of its self-administered system for transcranial direct current stimulation to potentially reduce craving for cocaine. (Cision)

Researchers Investigate Noninvasive Brain Stimulation for Epilepsy

Feb. 11, 2019 - A research project in the Netherlands is investigating noninvasive brain stimulation as a potential therapy for epilepsy. (Medical Xpress)

Company Announces a New Category / CPT Code for Its Responsive Neurostimulation System

Feb. 13, 2019 - NeuroPace announced that the American Medical Association has issued a new reimbursement code for review and interpretation of brain-activity data from its neurostimulation system that monitors and responds to focal epileptic seizures. The code went into effect Jan. 1, 2019. (NeuroNews)

Company Seeks Full-Body Conditional FDA Labeling for Its Sacral Neuromodulation System

Feb. 12, 2019 - Axonics has submitted data to the FDA to seek full-body conditional MRI labeling for its sacral neuromodulation system. (Seeking Alpha)

Publication Profiles North American Chapter President

Feb. 8, 2019 - The North American Neuromodulation Society president, Todd Sitzman, MD, is featured in a profile by the publication NeuroNews. (NeuroNews)

FDA Clearance Announced for Noninvasive Stimulation for Migraine Pain

Feb. 6, 2019 - The company electroCore LLC announced it has received an expanded FDA clearance for use of its noninvasive vagus nerve stimulator as an acute treatment for migraine pain in adults. (Pain Medicine News)

Article Features Patient who Received a Neurostimulation Implant for His Digestive Condition

Feb. 7, 2019 - An article profiles a man with gastroparesis in the U.K. who was implanted with a gastric electrical stimulator two months ago. (Daily Mail)

Observational Study Follows Recipients of Spinal Cord Stimulators

Feb. 7, 2019 - A prospective observational study that followed 402 patients for two years who had received a spinal cord stimulator was published in the European Journal of Pain. (Clinical Pain Advisor)

Company Announces Software Approval for Drug Delivery Device

Feb. 6, 2019 - Flowonix Medical announced FDA approval of clinician programmer software for its Prometra intrathecal infusion system. (Drug Delivery Business News)

Visual Prosthesis Undergoes Clinical Trial

Feb. 6, 2019 - An article describes a visual prosthesis undergoing clinical study in Australia in seven patients who have retinitis pigmentosum. (ZD Net)

Neurofeedback Studied in Parkinson's Disease Patients

Feb. 6, 2019 - Osaka University researchers published clinical research in eNeuro concerning neurofeedback for Parkinson's disease patients. (News-Medical Life Sciences)

Implant Unveiled in Patient with Amputated Hand

Feb. 5, 2019 - A patient with an amputated hand in Sweden has received an implant designed to operate a prosthesis. (Industry Europe)

Canadian Province to Provide More Deep Brain Stimulation Access for Parkinson's Disease Patients

Feb. 5, 2019 - The province of British Columbia, Canada, announced plans to increase access to deep brain stimulation for patients with Parkinson's disease with recruitment of an additional neurosurgeon. The province will provide for 72 surgeries in the coming fiscal year. There are 70 patients on a wait list for the surgery. (CBC)

Agency Reconsiders Coverage of Vagus Nerve Stimulation for Depression

Feb. 5, 2019 - An article anticipates an agency decision about Medicare and Medicaid coverage of implanted vagus nerve stimulators for patients with treatment-resistant depression. (MedTech Dive)

Neurostimulation Study Concentrates on Predominant Lower Back Pain

Feb. 1, 2019 - A study compared medical management alone and medical management with spinal cord stimulation for predominant lower back pain in failed back surgery syndrome patients. (Pain)

Article Surveys Current and Potential Opportunities for Canadian Patients with Depression to Use Repetitive Transcranial Magnetic Stimulation

Feb. 3, 2019 - An article examines the potential to expand access to repetitive transcranial magnetic stimulation for depression in Canada. (Globe and Mail)

Study Tracks Cognitive Function of Parkinson's Disease Patients after Deep Brain Stimulation

Feb. 1, 2019 - An observational study in Germany looked at Parkinson's disease patients who received deep brain stimulation, some of whom also had mild cognitive impairment, and tracked the progression to dementia in some of the patients. (Parkinsons News Today)

Researchers Investigate the Effects of Non-Invasive Nerve Stimulation on Tremor

Feb. 1, 2019 - Researchers published findings about transcutaneous alternating current stimulation of peripheral nerves and tremor. They also investigated placing the electrodes on the scalp above the motor cortex, and the effect of a topical anesthetic during that stimulation. (IEEE Spectrum)

Company Raises $8 Million in Series C Funding

Jan. 31, 2019 - According to an SEC filing, SPR Therapeutics has raised $8 million of a $20 million Series C round of funding that began in January. (Mass Device)

Device Company Launches Spinal Cord Stimulation System in Europe

Jan. 31, 2019 - Boston Scientific Corporation has launched the Spectra WaveWriter spinal cord stimulation system in Europe. (NeuroNews)

Paper: Epidural Spinal Cord Stimulation Helped Restore Movement for Two Paralyzed Patients in Their 50s - 60s

Jan. 31, 2019 - Researchers published about using epidural spinal cord stimulation to restore movement in two women who had paralysis-inducing spinal cord injury five and 10 years ago, respectively. (EurekAlert)

Study Investigates Non-Invasive Brain Stimulation to Address Negative Schizophrenia Symptoms

Jan. 30, 2019 - Researchers investigated transcranial magnetic stimulation to reduce negative symptoms in schizophrenia. (Science Daily)

FDA Requires Additional Time to Review a Pre-Market Approval Application

Jan. 30, 2019 - Nuvectra announced the FDA will extend its review period for the pre-market approval of the company's sacral neuromodulation system, past the 180-day deadline. (BioPortfolio)

Column Details Recovery and Early Stages of Deep Brain Stimulation Therapy

Jan. 29, 2019 - A woman describes her early months following deep brain stimulation surgery for Parkinson's disease. (Pendleton Times Post)

Company Receives CE Mark for MRI-Conditional Labeling of Neurostimulation System

Jan. 29, 2019 - Abbott has received CE mark approval for MRI-conditional labeling of its Infinity deep brain stimulation system. (NeuroNews International)

Study Evaluates Overactive Bladder Patients' Medication Use after Sacral Neuromodulation

Jan. 25, 2019 - A study found that more than 80% of overactive bladder patients who progressed to sacral neuromodulation discontinued their medications for the condition. (Journal of Urology)

Non-invasive Brain Stimulation Being Studied to Augment Therapy for Stuttering

Jan. 26, 2019 - A clinical trial at the University of Oxford in the U.K. will explore transcranial direct current stimulation and training in verbal fluency as a possible therapy for stuttering. (The Guardian)

Column Considers the Future of Neuromodulation

Jan. 25, 2019 - In a column, Prof. Dirk De Ridder, MD, PhD, discusses how the future of neuromodulation should include three things: better understanding of the brain; better technology; and artificial intelligence to develop "smart" neuromodulation therapy. (NeuroNews)

Paper Analyzes Published Studies of Interventional Treatment for Obsessive Compulsive Disorder

Jan. 24, 2019 - A meta-analysis of published studies compared the effectiveness of neuroabaltion and deep brain stimulation for treatment-resistant obsessive compulsive disorder. (British Medical Journal)

New Guidance Issued by NICE Concerning a Form of Spinal Cord Stimulation

Jan. 23, 2019 - The U.K. National Institute for Health and Care Excellence, NICE, has introduced new guidance on a form of spinal cord stimulation as a treatment option for chronic neuropathic back or leg pain after failed back surgery. (NICE)

U.S. Spinal Cord Stimulation Training Survey Results Published

Jan. 22, 2019 - A survey of current and past fellows in pain management programs focused on the extent or nature of training in spinal cord stimulation implantation. (Regional Anesthesia and Pain Medicine)

Rechargeable, Directional Deep Brain Stimulation System Launched

Jan. 25, 2019 - Boston Scientific announced launch of the rechargeable Vercise Gevia deep brain stimulation system and Vercise primary cell for the treatment of symptoms of Parkinson's disease. (NeuroNews)

Data Reported on High-Frequency Peripheral or Spinal Cord Stimulation in Pain Patients

Jan. 24, 2019 - Clinicians at an Australian facility gathered data on pain scores for 12 months in patients implanted with high-frequency spinal cord stimulators or peripheral nerve stimulators. (NeuroNews)

Review Offers Updated Overview of Neurostimulation for Chronic Pain

Jan. 24, 2019 - An article on "Neurostimulation for Intractable Chronic Pain" reviews interventions, mechanisms of action, clinical indications, and suggests areas of future advancements. (Brain Sciences)

Neuromodulation Presented as a Health Technology that May Aid the Opioid Crisis

Jan. 23, 2019 - A healthcare technology business story presents neuromodulation as being considered a partial solution for the opioid crisis. The article says specialists believe it should be offered earlier in the treatment process. It adds that research is taking place to determine which patients benefit most from newer neurostimulation modes and devices. (STAT)

Studies Examine Burst Stimulation Mode in Pain Patients

Jan. 22, 2019 - Abbott released results from the BOLD study of intermittent burst stimulation, and discussed a second study of spinal cord stimulation patients. (Mass Device)

Foundation Issues Grant for Pre-surgical Customization of Neurostimulation for Epilepsy

Jan. 22, 2019 - The Epilepsy Foundation awarded a $150,000 grant to Greg Worrell, MD, PhD, professor of neurology and chair of clinical neurophysiology at Mayo Clinic, for development of a protocol during surgical evaluation to test electrical stimulation parameters to optimize and personalize therapy to enhance seizure control. (Cision)

Deep Brain Stimulation Recipient in India Plans a Regional Tour to Teach About Managing Parkinson's Disease

Jan. 19, 2019 - A Parkinson's disease patient in India who has taken two road trips since 2016, after receiving a deep brain stimulation system, is planning a 40-day road trip with his wife that will cover 2,600 km from Bengaluru to Kathmandu. Along the way, he will educate people on managing the disease for a better life. (Deccan Herald)

Researchers: Non-invasive Brain Stimulation Motor Effects Can Be Caused by Non-invasive Peripheral Nerve Stimulation

Jan. 17, 2019 - Researchers say they have isolated mechanisms showing the reported effects of transcranial alternating current stimulation on the motor system can be caused by transcutaneous stimulation of peripheral nerves. (Nature Communications)

Neurostimulation Company Releases Six-Month Study Data

Jan. 17, 2019 - Stimwave released six-month data from a trial of its spinal cord stimulation system in patients with back and leg pain, in which high or low frequency stimulation was used. (Mass Device)

First Patient Enrolled in Study of Intrathecal Drug Delivery in Pain Patients Who Were Weaned Off of Oral Opioids

Jan. 17, 2019 - Medtronic announced enrollment of the first patient in a study of the use of its intrathecal drug delivery device in people with chronic intractable non-malignant primary back pain who have been weaned off of oral opioids. (Drug Delivery Business News)

Annual Research Prize for Junior Investigators Announced

Jan. 16, 2019 - There is a March 15, 2019 deadline for junior investigators aged 45 or younger, who have received an advanced degree in the past 10 years, to submit an entry for the Science and PINS Prize in Neuromodulation. The $25,000 prize is based on an essay about research performed in the past three years. The award was started in 2016 by Science magazine and PINS Medical of China. In addition to the cash award, winners have their essay published in Science magazine. (Science 2.0)

Israeli Company Prepares for US. Stock Exchange Offering

Jan. 15, 2019 - Brainsway Ltd. has filed a prospectus for a public offering on Nasdaq to raise at least $30 million. Timing of the offering depends upon when approval of the prospectus is received from the U.S. Securities and Exchange Commission, which was affected by the U.S. government shutdown. (Globes)

Industry Observers Discuss the Role of Neuromodulation in Pain Treatment

Jan. 15, 2019 - A news feature about neuromodulation and pain presents viewpoints about a larger context for the treatment, with one physician saying neuromodulation can be part of the answer to part of the opioid problem, and that with individual patients, expectation management is important. (Mass Device)

Company Plans Patient Registry

Jan. 14, 2019 - Bioness, Inc. announced that for its peripheral nerve stimulator, it has launched a patient registry, to which patients will be able to opt-in to join. (Cision)

Industry Association Unveils an Updated Code of Ethics

Jan. 9, 2019 - AdvaMed, the Advanced Medical Technology Association, has published an updated Code of Ethics on Interactions with U.S. Health Care Professionals that will take effect January 1, 2020. It updates guidance about a number of aspects, such as consulting arrangements, and adds guidance about factors such as conduct of company representatives and information about on- and off-label use of medical devices. (Lexology)

Column Presents Top Takeaways from an Expert Consensus Published in 2018

Jan. 11, 2019 - A column summarizes the top 10 takeaways from the 2018 publication, "The Neuromodulation Appropriateness Consensus Committee on Best Practices for Dorsal Root Ganglion Stimulation." (NeuroNews International)

Review Summarizes Reports on Advanced Methods of Spinal Cord Stimulation

Jan. 9, 2019 - Updating a review from 2014, a newly published review summarizes reports from 2010 - 2018 on "Advanced methods of spinal stimulation in the treatment of chronic pain: pulse trains, waveforms, frequencies, targets and feedback loops." (Expert Review of Medical Devices)

Headache Symposium Includes Preliminary Results from a Clinical Trial of a Wearable Device to Treat Migraine

Jan. 9, 2019 - Remarks at the 4th Annual International Headache Symposium in Israel included preliminary results of a randomized, double-blind, parallel group, sham-controlled clinical trial of a migraine treatment device that stimulates the occipital and trigeminal nerves. (Business Wire)

Thought Leader Calls for Ottawa to Fund Better Mental Health Treatments

Jan. 9, 2019 - A medical columnist points out that more than 16 years after Health Canada approved repetitive transcranial magnetic stimulation for depression, the only provincial health authorities to cover the treatment are in Quebec and Saskatchewan. (Ottawa Citizen)

A Personal Account of Choosing Neurostimulation to Treat Peripheral Neuropathy Pain

Jan. 9, 2019 - A news feature tells the story of a man who developed peripheral neuropathy and chose neurostimulation rather than surgery to treat the chronic pain. (University of Kentucky)

Current Neuromodulation Treatments for Migraine Considered

Jan. 8, 2019 - An article summarizes the state of neuromodulation devices approved for migraine treatment. (Medscape)

Company Reports New Clinical Trials in Noninvasive Vagus Nerve Stimulation for Migraine

Jan. 8, 2019 - ElectroCore, Inc. announced two clinical studies focused on expanding the use of non-invasive vagus nerve stimulation for acute and preventive treatment of migraine. The company also noted publication of a retrospective analysis of the treatment in a clinical trial in cluster headache patients. (Globe Newswire)

Visual Prosthetic Meets Six-Month Endpoints in Feasibility Study

Jan. 8, 2019 - Pixium Vision reported interim six-month follow-up results of a feasibility study of its visual prosthetic implant, a wireless sub-retinal photovoltaic microchip, in patients with advanced dry age-related macular degeneration. (Pharmalive)

Researchers Study Effect of Transcranial Stimulation on Motor Behavior

Jan. 4, 2019 - Researchers at the University of Tokyo studied the effect of transcranial static magnetic field stimulation (tSMS) on motor behavior in healthy subjects. The stimulation modulates cortical excitability. The researchers compared ballistic pinch force control before, during and after tSMS and sham interventions. (Neuromodulation: Technology at the Neural Interface)

Multicenter Study Reports Five-Year Experience of Sacral Neuromodulation Therapy for Urinary Voiding Dysfunction

Jan. 4, 2019 - A group of co-authors report on a five‐year, retrospective, multicenter study in China that evaluated the long‐term safety and efficiency of sacral neuromodulation in patients with urinary voiding dysfunction. (Neuromodulation: Technology at the Neural Interface)

FDA Clears Sinus Pain Device

Jan. 3, 2019 - TIVIC Health systems Inc. announced 510(k) clearance from the FDA for its transcutaneous, hand-held neurostimulation device to treat sinus pain due to allergic rhinitis. (PR Newswire)

New Device Company Launches

Jan. 3, 2019 - Dr. V. Reggie Edgerton announced formation of SpineX, a Los Angeles-based medical device company developing non-invasive devices to stimulate the spinal cord. (Globe Newswire)

Journal Article Categorizes Intervention Complications

Jan. 3, 2019 - Co-authors categorized complications for dorsal root ganglion stimulation for pain relief, which were reported in the MAUDE (Manufacturer and User Facility Device Experience) database. (Regional Anesthesia & Pain Medicine)

Neurostimulation Company Divests Subsidiary Focused on Neuroscience Clinical Animal Research Technology

Jan. 2, 2019 - Nuvectra Corporation announced it has agreed to sell its subsidiary NeuroNexus Technologies, Inc. to NEL Group, Inc., for $5 million in cash. (Globe Newswire)

Last Updated on Wednesday, March 13, 2019 03:55 PM